GlassScriptPhysician profile
Alexander Thomas Vaughan
NPI 1992147599
$3,298.95
in general payments reported to CMS, 2019-2025
12 companies · $182 in 2025
The $182 reported for 2025 was more than what 78% of Orofacial Pain providers received nationally (typical 2025 total: $95.41).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $124 · 2021: $1,304 · 2022: $136 · 2023: $19.86 · 2024: $1,121 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,321.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Somnomed INC. | $1,283.85 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $1,224.03 | 2021 | |
| Amgen INC. | $167.71 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $148.50 | 2019-2021 | |
| Inspire Medical Systems, INC. | $108.58 | 2019 | |
| Tactile Systems Technology INC | $79.65 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.48 | 2022 | |
| Dentsply Sirona INC | $62.15 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $61.97 | 2019-2021 | |
| Abbvie INC. | $47.18 | 2022-2023 | Qulipta |
| Aerin Medical INC. | $28.65 | 2022 | |
| Axsome Therapeutics, INC. | $18.20 | 2025 | Symbravo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Vaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.